Pfas Articles & Analysis
16 news found
Forever chemicals – also known as per and poly fluoralkyl substances (PFAS) – are a family of different compounds so called because of how they persist in the environment, with many (such as perfluorooctanoic acid and perfluorooctane sulfonic acid) associated with adverse effects in both animals and people. PFAS enjoy widespread use in a range of ...
NewGen Surgical products are California Prop 65 compliant; free of intentionally added BPA or BPA derived plastics, mercury, phthalates, PFAs, and PVC, and are USDA BioPreferred certified. Currently, the company offers 6 product lines, available direct or through major national distributors and internationally with approved CE mark. ...
NewGen Surgical products are California Prop 65 compliant; free of intentionally added BPA or BPA derived plastics, mercury, phthalates, PFAs and PVC. Currently the company offers 6 product lines, available direct or through major national distributors and internationally with approved CE mark. ...
NewGen Surgical products are California Prop 65 compliant; free of intentionally added BPA or BPA derived plastics, mercury, phthalates, PFAs and PVC. Currently the company offers 6 product lines, available direct or through major national distributors and internationally with approved CE mark. ...
Johnson & Johnson MedTech* announced today that Biosense Webster, Inc., a worldwide leader in the science and technology of cardiac arrhythmia treatment, enrolled the first patients in its admIRE clinical study in the United States. admIRE is a prospective, multi-center, non-randomized study that will enroll more than 400 patients in the U.S. to evaluate the safety and effectiveness of ...
The patients, a 32-year-old man with paroxysmal AF and a 60-year-old man with persistent AF underwent successful pulmonary vein and posterior wall isolation using a dedicated PFCA catheter powered by the proprietary Adagio iCLAS™ cryoablation and pulsed field ablation (PFA) consoles. “PFCA is a unique combination of Adagio’s ultra-low temperature cryoablation ...
Pulsed field ablation is an innovative therapy that uses electric fields to treat heart tissue. PFA delivered by the Globe PF System is unique in that it achieves true single-shot isolation; a single application of the GlobePulse™ Waveform achieves pulmonary vein isolation (PVI) in as little as 3 seconds. ...
“The vision for pioneering Pulsed Field Ablation treatment was primarily due to PFA’s ability to have high-impact treatment while preserving healthy tissue. ...
We have recently announced the initiation of the study in patients with monomorphic VT and are actively pursuing pulsed field cryoablation (PFCA), which combines ULTC and pulsed field ablation (PFA) technologies.” “There is a unique, physiologic synergy between ultra-low temperature cryoablation and pulsed field ablation,” said Dr. ...
The acquisition will complement the existing Boston Scientific electrophysiology portfolio to include the FARAPULSE Pulsed Field Ablation (PFA) System – a non-thermal ablation system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. ...
'The ADVENT Trial is uniquely positioned to change our field: it is not only the first pivotal trial of PFA but also the only randomized one approved to commence by the FDA. ...
("FARAPULSE" or "the Company") today announced that it has received the Conformite Europeene (CE) Mark for its FARAPULSE Pulsed Field Ablation (PFA) system for the treatment of Paroxysmal Atrial Fibrillation (AF). The approval makes FARAPULSE the first company in the world to commercialize a cardiac PFA system and permits marketing of the system across the ...
” The financing will also allow Kardium to begin additional clinical studies of a new version of the Globe System that uses pulsed field ablation (PFA), a new energy source for cardiac ablation. PFA has the potential to perform faster and safer ablations due to the non-thermal and tissue-selective nature of the energy source. ...
Food and Drug Administration (FDA) conditionally approved the Company’s Investigational Device Exemption (IDE) application to initiate its U.S. pivotal ADVENT trial to evaluate the safety and effectiveness of its Pulsed Field Ablation (PFA) system for the treatment of paroxysmal Atrial Fibrillation (AF). ...
Boston Scientific Corporation (NYSE: BSX) today announced it has signed an investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed field ablation (PFA) system for the treatment of atrial fibrillation (AF) and other cardiac arrhythmias. This PFA system – comprising a sheath, generator and ...
EPA has also issued other Significant New Use Rules on perfluorinated chemicals, including perfluorooctane sulfonate (PFOS) and perfluoroalkyl sulfonates (PFAS) that were voluntarily phased-out of production. This proposal requires that anyone who intends to import these perfluorinated chemicals, including in products, or domestically produce or process these chemicals for any ...